Plants and mushrooms of abuse.
D G Spoerke, A H Hall
Emergency medicine clinics of North America August 1, 1990 DOI: 10.1016/s0733-8627(20)30261-3 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Keywords | Humans Basidiomycota Plants Substance-related disorders Ambulatory care |
| Key findings | The authors argue that Emergency Department physicians need to recognize the abuse potential of psychoactive plants, their probable side effects, and the need for appropriate, usually supportive, treatment. Because the active ingredients are pharmacologically similar to LSD and amphetamine, treatment is often similar. Identification of the offending botanical agent can be problematic, and most of these plants are legal to possess. |
Abstract
The plants described earlier are only a few of those that can be misused. Most have effects similar to those of more popular synthetic drugs but can cause unpleasant side effects and unpredictable results. Identification of the offending botanic agent can be problematic. These plants are still used because most are legal to possess, and they do produce desired hallucinogenic and stimulant effects. Because the active ingredients are similar pharmacologically to agents such as LSD and amphetamine, required treatment is often similar. The challenge for the Emergency Department physician is to recognize the potential for abuse of these botanic agents, their probable side effects, and the need for appropriate, usually supportive, treatment. There are many more plants with abuse potential than can be discussed in detail in an article of this size. Table 1 lists a number of other agents that might be misused. Phenylamine hallucinogens occur in several species and include N,N-dimethyltryptamine (DMT), N-monomethyltryptamine (MMT), 5-methoxy-N-N-dimethyltryptamine (5-MeO-DMT), 5-methoxy-N-monomethyltryptamine (5-MeO-DMT), 5-methoxy-N-monomethyltryptamine (5-MeO-MMT), 5-hydroxy-N-N-dimethyltryptamine (bufotenine or 5-H-DMT), and N,N-dimethyltryptamine-N-oxide (DMT-N-oxide).
Citations in the library
Cited by 5
- Toward a Comparative Overview of Dependence Potential and Acute Toxicity of Psychoactive Substances Used Nonmedically The American Journal of Drug and Alcohol Abuse 1993
- Bufo toads and bufotenine: fact and fiction surrounding an alleged psychedelic. Journal of Psychoactive Drugs 1996
- Occurrence and use of hallucinogenic mushrooms containing psilocybin alkaloids TemaNord May 19, 2009
- Hallucinogenic plants of abuse Emergency Medicine Australasia April 1, 2008
- NMR spectral assignments of a new chlorotryptamine alkaloid and its analogues from Acacia confusa. Magnetic resonance in chemistry : MRC April 2007
Cites 11
- Visual Phenomenology of the LSD Flashback Archives of General Psychiatry August 1, 1983
- Clinical toxicology of ‘magic mushroom’ ingestion Postgraduate Medical Journal September 1, 1981
- Patterns of Hallucinogenic Drug Abuse JAMA January 11, 1965
- Abuse of Indigenous Psilocybin Mushrooms: A New Fashion and Some Psychiatric Complications The British Journal of Psychiatry June 1, 1978
- The Problem of Psilocybin Mushroom Abuse Human Toxicology October 1, 1982
and 6 more in the library